Immunodeficient Rabbit Models: History, Current Status and Future Perspectives
Author: Song, Jun; Pallas, Brooke; Yang, Dongshan; Zhang, Jifeng; Agarwal, Yash; Chen, Y. E.; Bility, Moses; Xu, Jie. 2020.
Publication: Applied Sciences 2020, Vol. 10, Page 7369
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Production of immunodeficient (ID) models in non-murine animal species had been extremely challenging until the advent of gene-editing tools: first zinc finger nuclease (ZFN), then transcription activator-like effector nuclease (TALEN), and most recently clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR)/Cas9. We and others used those gene-editing tools to develop ID rabbits carrying a loss of function mutation in essential immune genes, such as forkhead box protein N1 (FOXN1), recombination activating gene 1/2 (RAG1/2), and interleukin 2 receptor subunit gamma (IL2RG). Like their mouse counterparts, ID rabbits have profound defects in their immune system and are prone to bacterial and pneumocystis infections without prophylactic antibiotics. In addition to their use as preclinical models for primary immunodeficient diseases, ID rabbits are expected to contribute significantly to regenerative medicine and cancer research, where they serve as recipients for allo- and xeno-grafts, with notable advantages over mouse models, including a longer lifespan and a much larger body size. Here we provide a concise review of the history and current status of the development of ID rabbits, as well as future perspectives of this new member in the animal model family.
Cite this article
Song J, Pallas B, Yang D, Zhang J, Agarwal Y, Chen YE, Bility M, Xu J. Immunodeficient Rabbit Models: History, Current Status and Future Perspectives. Applied Sciences. 2020; 10(20):7369.https://doi.org/10.3390/app10207369
